文献速递心血管MR

慢性重度原发性二尖瓣反流瓣膜修复术后心肌逆重构

Reverse Myocardial Remodeling Following Valve Repair in Patients With Chronic Severe Primary Degenerative Mitral Regurgitation.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-08-18

多中心前瞻性研究纳入104例原发性二尖瓣反流行二尖瓣修复术患者,术前行心脏磁共振LGE、ECV%和iECV评估心肌纤维化,术后≥6个月复查。结果显示术后ECV%和iECV显著降低而LGE发生率不变,术前iECV可预测术后左室重构程度。

要点

  • 术后ECV%和iECV显著降低,提示弥漫性心肌纤维化部分可逆。
  • 术前iECV≥17.6 mL/m2者术后左室收缩末容积指数更大。
  • 术前ECV%和LGE不影响术后功能,LGE发生率术后无变化。

核心结论

  • 二尖瓣修复术后ECV%和iECV降低,术前iECV可独立预测术后左室重构程度,且不受症状影响。

关键影像表现/征象

  • 术后ECV%从27.4%降至26.6%(P=0.027),iECV从17.9降至15.4 mL/m2(P<0.001),LGE发生率不变。
  • 术前iECV≥17.6 mL/m2者术后左室收缩末容积指数显著更大(30.5±12.7 vs 23.9±8.0 mL/m2,P=0.003)。
  • 术前iECV预测术后左室收缩末容积指数(β=1.04;95%CI 0.49-1.58;P<0.001)和左室射血分数(β=-0.61;95%CI -1.05至-0.18;P=0.006)。

诊断标准与关键数值

  • 以心脏磁共振LGE、ECV%和iECV评估心肌纤维化,iECV中位数阈值17.6 mL/m2用于分组分析。

临床应用与阅片要点

  • 术前心脏磁共振测量iECV有助于识别术后左室重构风险较高的二尖瓣反流患者。
  • 弥漫性心肌纤维化(ECV%、iECV)在瓣膜修复术后可部分逆转,而局灶性LGE不改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aims of this study were to quantify preoperative myocardial fibrosis using late gadolinium enhancement (LGE), extracellular volume fraction (ECV%), and indexed extracellular volume (iECV) on cardiac magnetic resonance; determine whether this varies following surgery; and examine the impact on postoperative outcomes.

BACKGROUND: Myocardial fibrosis complicates chronic severe primary mitral regurgitation and is associated with left ventricular dilatation and dysfunction. It is not known if this nonischemic fibrosis is reversible following surgery or if it affects ventricular remodeling and patient outcomes.

METHODS: A multicenter prospective study was conducted among 104 subjects with primary mitral regurgitation undergoing mitral valve repair. Cardiac magnetic resonance and cardiopulmonary exercise stress testing were performed preoperatively and ≥6 months after surgery. Symptoms were assessed using the Minnesota Living With Heart Failure Questionnaire.

RESULTS: Mitral valve repair was performed for Class 2a indications in 65 patients and Class 1 indications in 39 patients. Ninety-three patients were followed up at 8.8 months (IQR: 7.4 months-10.6 months). Following surgery, there were significant reductions in both ECV% (from 27.4% to 26.6%; P = 0.027) and iECV (from 17.9 to 15.4 mL/m2; P < 0.001), but the incidence of LGE was unchanged. Neither preoperative ECV% nor LGE affected postoperative function, but iECV predicted left ventricular end-systolic volume index (β = 1.04; 95% CI: 0.49 to 1.58; P < 0.001) and left ventricular ejection fraction (β = -0.61; 95% CI: -1.05 to -0.18; P = 0.006). Patients with above-median iECV of ≥17.6 mL/m2 had significantly larger postoperative values of left ventricular end-systolic volume index (30.5 ± 12.7 mL/m2 vs 23.9 ± 8.0 mL/m2; P = 0.003), an association that remained significant in subcohort analyses of patients in New York Heart Association functional class I.

CONCLUSIONS: Mitral valve surgery results in reductions in ECV% and iECV, which are surrogates of diffuse myocardial fibrosis, and preoperative iECV predicts the degree of postoperative remodeling irrespective of symptoms. (The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation; NCT02355418).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Liu B, Neil DAH, Bhabra M, et al. Reverse Myocardial Remodeling Following Valve Repair in Patients With Chronic Severe Primary Degenerative Mitral Regurgitation. JACC Cardiovasc Imaging. 2021. PMID: 34419393. doi:10.1016/j.jcmg.2021.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。